The Hidden Burden of Fractures in People Living With HIV
- PMID: 30283906
- PMCID: PMC6139727
- DOI: 10.1002/jbm4.10055
The Hidden Burden of Fractures in People Living With HIV
Abstract
The survival of people living with human immunodeficiency virus (HIV) has increased markedly since the advent of antiretroviral therapy (ART). However, other morbidities have emerged, including osteoporosis. The estimated incidence of fractures at any site in people living with HIV ranges from 0.1 per 1000 person-years to 8.4 per 1000 person-years: at least twice that of people without HIV. This increased risk seems to be related to HIV itself and its treatment. Risk factors for bone disease in HIV-positive (HIV+) subjects include both classical risk factors for osteoporosis and fracture and factors linked to HIV itself, such as inflammation, reconstitution syndrome, low CD4, ART, and co-infection with hepatitis B and C viruses. The risk of fractures in these individuals can be at least partially assessed by measurement of BMD and the Fracture Risk Assessment Tool (FRAX™). Only alendronate and zoledronic acid have been studied in HIV+ individuals; both show beneficial effects on BMD, although data on fracture reduction are not available. © 2018 The Authors. JBMR Plus Published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
Keywords: AIDS; Fracture; HIV; Osteoporosis.
Figures
References
-
- Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. Feb 1993;328(5):327–35. - PubMed
-
- Palella FJ, Jr. , Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. Mar 1998;338(13):853–60. - PubMed
-
- Fang CT, Chang YY, Hsu HM, et al. Life expectancy of patients with newly‐diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM. Feb 2007;100(2):97–105. - PubMed
-
- van Sighem AI, Gras LA, Reiss P, et al. Life expectancy of recently diagnosed asymptomatic HIV‐infected patients approaches that of uninfected individuals. AIDS. Jun 2010;24(10):1527–35. - PubMed
-
- Collaboration of Observational HIVEREiE, Lewden C, Bouteloup V, et al. All‐cause mortality in treated HIV‐infected adults with CD4 >/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. Apr 2012;41(2):433–45. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials